RS
HUMA icon

R Squared’s Humacyte HUMA Stock Holding History

R Squared’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.8K Sell
31,805
-31,106
-49% -$28.8K 0.01% 480
2026
Q1 		$38.2K Buy
62,911
+36,758
+141% +$38.2K 0.02% 432
2025
Q4 		$25.1K Buy
+26,153
New +$37K 0.01% 486
2025
Q2 		– Sell
-11,180
Closed -$19.1K – 512
2025
Q1 		$19.1K Buy
11,180
+8,230
+279% +$30.9K 0.02% 281
2024
Q4 		$14.9K Buy
+2,950
New +$14.6K 0.01% 1016

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

R Squared's HUMA Position: Q2 2026 in Review

R Squared reduced its Humacyte (HUMA) stake by 49% in Q2 2026, selling an estimated $28.8K and leaving 31,805 shares worth $24.8K. The position accounts for 0.01% of the portfolio, ranked #480.

R Squared first reported a position in HUMA in Q4 2024 and has held it in 5 quarters since. The position peaked at $38.2K in Q1 2026. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • R Squared held 31,805 shares of Humacyte worth $24.8K as of Q2 2026.
  • R Squared sold 31,106 Humacyte shares in Q2 2026, an estimated $28.8K.
  • Humacyte made up 0.01% of R Squared's portfolio in Q2 2026, its #480 holding.
  • R Squared first reported a position in Humacyte in Q4 2024 and has held it in 5 quarters since.
  • R Squared's Humacyte position peaked at $38.2K in Q1 2026.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.